Literature DB >> 16343648

Pediatric cholesteatoma: a retrospective review.

Scott A Schraff1, Barry Strasnick.   

Abstract

OBJECTIVES: The optimal treatment for pediatric cholesteatoma is controversial. Management decisions including intact canal wall versus open cavity techniques, second look procedures and staging ossicular reconstruction continue to be debated. In an attempt to clarify this issue we conducted an 11-year retrospective analysis of our experience with cholesteatoma presenting in our pediatric population. STUDY
DESIGN: Retrospective review of children undergoing surgical intervention for cholesteatoma at a tertiary care pediatric hospital between 1 July 1992 and 1 July 2003 by the senior author.
METHODS: Comparison of recurrence rates in intact canal wall (ICW) versus canal wall down (CWD) procedures; with analysis of second-look procedures, ossicular chain reconstruction (OCR) and hearing results in the management of pediatric cholesteatoma.
RESULTS: Two hundred and sixty-two children with 278 cases of cholesteatoma underwent surgical resection. Of these children, 221 were managed via an ICW approach while the remaining 57 underwent a CWD procedure. The overall recurrence rate in this series was 16%, with 17% in the ICW group and 12% in the CWD group. OCR was performed in 97% of the ICW cases at time of second-look procedure, with 75% undergoing reconstruction with partial ossicular reconstruction prosthesis. The average air-bone gap improvement in these patients was 10.8 dB, with an average hearing improvement of total ossicular reconstruction of 5.8 dB. The average hearing improvement in the CWD group, all managed with cartilage interposition grafts, was 3.7 dB.
CONCLUSIONS: Management of pediatric cholesteatoma requires a highly individualized approach that takes into account anatomic, clinical and social factors to determine the most successful surgical treatment paradigm.

Entities:  

Mesh:

Year:  2005        PMID: 16343648     DOI: 10.1016/j.ijporl.2005.10.006

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  8 in total

1.  Dealing with paediatric cholesteatoma: how we changed our management.

Authors:  B Sergi; J Galli; M Battista; E De Corso; G Paludetti
Journal:  Acta Otorhinolaryngol Ital       Date:  2014-04       Impact factor: 2.124

2.  Predictive Role of Ki-67 and Proliferative-Cell Nuclear Antigen (PCNA) in Recurrent Cholesteatoma.

Authors:  Ela Araz Server; Çiğdem Kalaycık Ertugay; Sevim Baykal Koca; Ecem Sevim Longur; Özgür Yiğit; Hasan Demirhan; Yasemin Çakır
Journal:  J Int Adv Otol       Date:  2019-04       Impact factor: 1.017

3.  Expression of pattern recognition receptors in cholesteatoma.

Authors:  Ho Yun Lee; Moon Suh Park; Jae Yong Byun; Young Il Kim; Seung Geun Yeo
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-02-26       Impact factor: 2.503

Review 4.  A review of current progress in acquired cholesteatoma management.

Authors:  Chin-Lung Kuo; Wen-Huei Liao; An-Suey Shiao
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-09-17       Impact factor: 2.503

Review 5.  Long-term surgical and functional outcomes of the intact canal wall technique for middle ear cholesteatoma in the paediatric population.

Authors:  S C Prasad; C La Melia; M Medina; V Vincenti; A Bacciu; S Bacciu; E Pasanisi
Journal:  Acta Otorhinolaryngol Ital       Date:  2014-10       Impact factor: 2.124

Review 6.  Updates and knowledge gaps in cholesteatoma research.

Authors:  Chin-Lung Kuo; An-Suey Shiao; Matthew Yung; Masafumi Sakagami; Holger Sudhoff; Chih-Hung Wang; Chyong-Hsin Hsu; Chiang-Feng Lien
Journal:  Biomed Res Int       Date:  2015-03-18       Impact factor: 3.411

7.  Surgical management of middle ear cholesteatoma and reconstruction at the same time.

Authors:  Pedro Blanco; Francisco González; Jorge Holguín; Claudia Guerra
Journal:  Colomb Med (Cali)       Date:  2014-09-30

8.  Delays in surgery for cholesteatoma due to COVID-19: is there an impact on rates of recidivism and major complications?

Authors:  Mohammed Hassan Hussain; Manish Mair; Sara Mahmood; Georgios Sakagiannis; Djamila M Rojoa; Firas J Raheman; Esmee Irvine; Peter Rea
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-10-10       Impact factor: 2.503

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.